US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme
Pfizer buys stake in French vaccine maker Valneva

Daily 1-pager M&A Snapshot for Deal Makers
US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme